JZ1.24
Therapeutic area
Neurodegenerative
Target disease
Multiple sclerosis
Study phase
Preclinical: In vitro
100%
Preclinical: In vivo
100%
Clinic I
0
Clinic II
Not initiated
Clinic III
Not initiated
Patent No.
Patent application No. ES201830841